0
uniQure N.V.
- 201-500 Employees
- Based in Amsterdam, Netherlands
uniQure is delivering on the promise of gene therapy – single treatments with potentially curative results. They are leveraging their modular and validated technology platform to rapidly advance a pipeline of proprietary gene therapies to treat patients with hemophilia B, Huntington's disease, Fabry disease, spinocerebellar ataxia Type 3 and other diseases.
uniQure N.V.
Most Recent Responsibility Report
Our service enables potential investors to review the most recent and archived uniQure N.V. Sustainability Report, uniQure N.V. Corporate Social Responsibility Report, uniQure N.V. CSR Report, uniQure N.V. Corporate Responsibility, uniQure N.V. CR Report, uniQure N.V. Citizenship Report, uniQure N.V. ESG Report, and uniQure N.V. Environmental Report online.